Science Explorer Interactive view Map
City · China

Research in Lianyun

Science Explorer records 4 research institutions in Lianyun, China. The highest-ranked on research quality in 2022–2025 are The First People’s Hospital of Lianyungang, Kanion Pharmaceutical (China) and Lianyungang Maternal and Children’s Hospital.

Research institutions
4
3 of them ranked worldwide
Research works
2.6k
▲ 23% vs 2013–17
Top-10% rate, 2022–2025
18.3%
record average 16.5%

A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.

Which research institutions are in Lianyun?

#InstitutionWorksAgainst the largest hereWorld rank
1The First People’s Hospital of LianyungangHospital / health system 1,857 #5,695
2Kanion Pharmaceutical (China)Company 530 #14,397
3Lianyungang Maternal and Children’s HospitalHospital / health system 198 #18,916
4Hansoh Pharma (China)Company 57 not ranked

By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.

How concentrated the city is

The same institutions as shares of everything the list accounts for. A city that is one university and a city that is twelve read alike as a table and not at all alike here.

The First People’s Hospital of Lianyungang: 70.3%Kanion Pharmaceutical (China): 20.1%Lianyungang Maternal and Children’s Hospital: 7.5%Hansoh Pharma (China): 2.2%70%largest
The First People’s Hospital of Lianyungang1,857 · 70.3%Kanion Pharmaceutical (China)530 · 20.1%Lianyungang Maternal and Children’s Hospital198 · 7.5%Hansoh Pharma (China)57 · 2.2%

Shares of the rows listed above, not of the whole node.

What is Lianyun strongest at in research?

Relative to its size, research in Lianyun is most concentrated in Cancer Research and Immunology (10.0× the world share in Cancer Research).

  1. Cancer ResearchSubfield · 34.1 works10.0×
  2. ImmunologySubfield · 27.7 works5.1×
← less than its size predicts1×more →

Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.

Which keywords describe research in Lianyun?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Oxidative Stress, Biomarkers, Epidemiology, Tumor Microenvironment, Antioxidant and Metastasis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer84▲ 8.0×52 topics
  2. Inflammation84▲ 5.1×75 topics
  3. Epidemiology59▲ 1.89×104 topics
  4. Oxidative Stress53▲ 4.1×55 topics
  5. Biomarkers32▲ 6.0×16 topics
  6. Cardiovascular Disease29▲ 3.3×30 topics
  7. Antioxidant29▲ 5.3×34 topics
  8. Tumor Microenvironment26▲ 7.6×7 topics
  9. Gene Expression26▲ 5.4×14 topics
  10. Metastasis24▲ 8.8×11 topics
  11. Regulation22▲ 5.1×10 topics
  12. Biogenesis20▲ 14×3 topics
  13. Chemotherapy20▲ 3.6×23 topics
  14. Herbal Medicine19▲ 8.3×9 topics
  15. Anti-inflammatory18▲ 8.2×18 topics
  16. Metabolic Syndrome18▲ 2.8×21 topics
  17. Traditional Chinese Medicine17▲ 18×5 topics
  18. Cell Death17▲ 9.4×6 topics
  19. Metabolism17▲ 4.2×25 topics
  20. Clinical Practice Guidelines17▲ 4.0×14 topics
  21. Immunity17▲ 5.3×10 topics
  22. Cytokines17▲ 7.5×8 topics
  23. Epigenetic Regulation16▲ 9.6×5 topics
  24. Immune Response16▲ 3.6×19 topics
  25. Innate Immunity14▲ 5.7×11 topics
  26. Neuroinflammation14▲ 6.4×6 topics
  27. Apoptosis14▲ 5.8×20 topics
  28. Bioactive Compounds13▲ 6.6×7 topics
  29. Cell Differentiation13▲ 18×2 topics
  30. Pharmacology13▲ 6.6×16 topics
  31. Sepsis13▲ 9.7×6 topics
  32. RNA Regulation13▲ 15×2 topics
  33. Long Noncoding RNAs13▲ 19×1 topic
  34. Transcriptional Landscape13▲ 19×1 topic
  35. Antiviral12▲ 19×3 topics
  36. Cancer Progression12▲ 8.1×8 topics
  37. Disease12▲ 17×3 topics
  38. Phytochemistry11▲ 11×6 topics
  39. Therapeutics11▲ 13×2 topics
  40. Cancer Biomarkers11▲ 16×3 topics

What research is done in Lianyun?

Cancer-related molecular mechanisms research: 13 fractional worksMicroRNA in disease regulation: 9 fractional worksFerroptosis and cancer p…9Ferroptosis and cancer prognosis: 9 fractional worksCircular RNAs in diseases8Circular RNAs in diseases: 8 fractional worksRNA modifications and cancer: 7 fractional worksPharmacological Effects of Natural Compounds: 7 fractional worksTraditional Chinese Medi…5Traditional Chinese Medicine Analysis: 5 fractional worksNeuroinflammation and Neurodegeneration Mechanisms: 5 fractional worksInflammatory Biomarkers in Disease Prognosis: 5 fractional worksSepsis Diagnosis and Treatment: 5 fractional works
Cancer ResearchPulmonary and Respiratory MedicineMolecular BiologyPharmacology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related molecular mechanisms research Cancer Research 13 works
  2. 2 MicroRNA in disease regulation Cancer Research 9 works
  3. 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 9 works
  4. 4 Circular RNAs in diseases Molecular Biology 8 works
  5. 5 RNA modifications and cancer Molecular Biology 7 works
  6. 6 Pharmacological Effects of Natural Compounds Pharmacology 7 works
  7. 7 Traditional Chinese Medicine Analysis Complementary and alternative medicine 5 works
  8. 8 Neuroinflammation and Neurodegeneration Mechanisms Neurology 5 works
  9. 9 Inflammatory Biomarkers in Disease Prognosis Oncology 5 works
  10. 10 Sepsis Diagnosis and Treatment Epidemiology 5 works

Research output over time

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more.